NEW YORK, NY / ACCESSWIRE / April 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased ExamWorks Group, Inc. (NYSE: EXAM) stock prior to April 27, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of ExamWorks to an affiliate of Leonard Green & Partners, L.P. for $35.05 in cash per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/examworks-exam or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 439284

NEW YORK, NY / ACCESSWIRE / April 27, 2016 / Development stage biotech company MetaStat Inc (OTCQB: MTST) just announced a high-profile, and potentially game changing addition to its board of directors. As of April 26, 2016, Jerome
B. Zeldis, M.D., Ph.D, Chief Medical Officer of Celgene Corporation (NASDAQ:CELG) and Chief Executive Officer of Celgene Global Health, will join the Metastat board as its vice chairman. For a company the size of MetaStat, which had a market capitalization of a little over $3.42 million at last count, the addition of an industry professional with the standing of Zeldis is a validation of the potential of its lead diagnostics technology – something we will touch on in a little more detail shortly.

Who Is Jerome B.
Zeldis?

Zeldis, holds one of the top positions at Celgene – an $85 billion healthcare behemoth – and as such, he represents an opportunity for MetaStat to forge a relationship, and going forward, perhaps a partnership, with big pharma. MetaStat’s technology is an oncology focus, and specifically in its current form, a breast cancer focus. Celgene markets some of the industry’s most well-known compounds for this indication – Abraxane, the injectable paclitaxel, being one example.

Prior to joining Celgene, Zeldis held academic professorship positions at Cornell and Harvard, and worked clinical positions at both Sandoz Research Institute and Janssen Research Institute – two of the leading research institutions in the US.

Why would somebody of the background, and current professional standing, choose to help a company the size of MetaStat with its development program? There’s only one real answer, and that is he believes the company’s pipeline can carry through to commercialization. So, with this said, what is MetaStat working on?

What is Metastat
Working On?

As mentioned, the company has an oncology focus – specifically, an epithelial-based cancer diagnostics tool. Its lead candidate, the MetaSite Breast assay, is a breast cancer focus, designed to provide insight into the likelihood of solid tumor metastasis.

Why is this
important?

Solid tumors very rarely lead to death. Instead, it is their metastasis (i.e. their spreading to the blood, or other areas of the body) that results in the complications most commonly associated with life-threatening late stage cancer. At present, there is no surefire way to determine whether a solid tumor is likely to metastasize, and so physicians will usually err on the side of caution and aggressively treat solid tumors with SOC therapies such as chemotherapy and radiotherapy. Alternatively, they will perform invasive surgery to attempt removal of the solid tumor, although, of course, this is not always possible. If the tumor was to metastasize, either of these options are valid and justifiable treatment methods. If not, however, they can result in unnecessary suffering for the patient. The ability to differentiate between these two scenarios could help patients avoid this unnecessary suffering, and that’s where the MetaSite Breast comes in.

“The diagnostics tool is rooted in what’s called the Mena protein. During the early stages of our development, this protein is responsible for helping cells to move from one location to another, and plays a key role in the development of the nervous system. Once we are developed, however, Mena protein expression declines.” Studies have shown that in certain solid tumors, Mena protein expression pick up. Further, the presence of the protein increases the invasiveness of cancer cells, and correlates with the likelihood of these cells spreading (i.e. metastasizing) beyond their solid state location. MetaStat has also located what it calls the MetaSite (hence the name of the technology), which refers to the window – for lack of a better phrase – through which cancer cells spread from one part of the body into the blood. MetaSite Breast uses a staining technology as a biomarker for both MetaSites and Mena proteins, and uses the degree to which both are present to calculate the chances of the tumor in question metastasizing. In short, these technologies, once developed will play a major role in not only mapping cancer but also in helping defeat it by applying the proper treatments in more localized environments.

This has happened
before

Back in 2012, development stage biotech Alliqua Biomedical Inc (NASDAQ: ALQA)
announced that Zeldis had joined its board of directors, just as he has now done with MetaStat. Less than a year later, the two companies announced a transaction in which Celgene invested $6 million in Alliqua, and the latter received a license to one of Celgene’s lead wound care products. Since then, the relationship between the two companies has strengthened, and they now have a number
of licensing agreements in place that will complement use of each others technology and healthcare products. It is safe to assume this partnership wouldn’t have come around so quickly, if at all, without Zeldis bridging the gap between the two companies.

Conclusion

Regardless of Zeldis’ motive, this demonstrates validation for Metastats’ technology and will offer the company many perks by having his guidance. The company now has a board member from the top of the healthcare industry, which in a space like development stage biotech can make a huge difference to a pipeline.

The post Celgene Corporation (NASDAQ: CELG) CMO Joins MetaStat Inc (OTCMKTS:MTST) Board appeared first on Market Exclusive.

SOURCE: Market Exclusive

ReleaseID: 439283

NEW YORK, NY / ACCESSWIRE / April 27, 2016 / The Stock Expert is issuing a report on four stocks that are performing well this Tuesday. SRPT, LGCY, ORIG and AMRS are on high volume alert. Continue reading to find out why. – To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.

Legacy Reserves LP (NASDAQ: LGCY) The company acquires and develops oil and natural gas properties primarily in the Permian Basin, East Texas, Rocky Mountain, and Mid-Continent regions of the United States.

When we first alerted you on LGCY, the stock has been one of the hottest stocks on the Nasdaq in April, tripling its share price in just 1 months, rarely with a down day.

LGCY is continuing this trend even higher today, up over 17% off heavier than usual volume. For the past 4 trading periods, LGCY has been the recipient of an influx of volume, however, with an RSI (relative strength index) of 86.70, the stock may need a little time to cool off before going higher.

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Ocean Rig UDW Inc. (NASDAQ: ORIG) Is an offshore drilling contractor, which provides oilfield services for offshore oil and gas exploration, development, and production drilling worldwide.

Like LGCY, ORIG has been one of the hottest stocks on the Nasdaq this month, trading higher by about 100% in April, with very few down days.

The stock is also getting a boost after announcing the acquisition of Ultra Deepwater Drillship just two days ago. – ORIG and LGCY have a lot of momentum moving into next month.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Is an agricultural biotechnology company that engages in crop seed breeding and genetic improvement activities in the Peoples Republic of China.

Shares of SRPT are trading lower today by off heavier than usual volume this morning after an FDA advisory panel has recommended against approving Sarepta Therapeutics’ promising drug for DMD.

SRPT hit its 52 week low after the news yesterday after a massive selloff occurred and today appears to be a continuation of the trend.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

Amyris, Inc. (NASDAQ: AMRS) The Company provides various alternatives to a range of petroleum-sourced products worldwide.

Shares of AMRS are trading higher today by over 20% after announcing the execution of their five year Biofene supply agreement with a global nutraceuticals company, expects total revenue from the agreement to be more than $100 million.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About TheStockExpert.com

The Stock Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “STOCKEXPERT”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The Stock Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The Stock Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit TheStockExpert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The Stock Expert
info@thestockexpert.com

SOURCE: The Stock Expert

ReleaseID: 439281

TORONTO, ON / ACCESSWIRE / April 27, 2016 / Eco Atlantic Oil & Gas Ltd. (TSXV: EOG) (“Eco Atlantic” or “the Company”) is pleased to announce that, as a result of meeting and exceeding its exploration work obligations, it has requested and received various approvals from the Namibia Ministry of Mines and Energy (“Ministry“) relating to the Cooper (PEL 030), Guy (PEL 034) and Sharon (PEL 033) Licenses offshore Namibia.

Cooper Block (PEL_030)

In recognition of the Company and its Partners, Tullow Kudu Ltd., AziNam and NAMCOR, having met and exceeded all obligations of the Initial Exploration Period as stipulated in the Petroleum Agreement (“Petroleum Agreement“), in Block 2012A (the “Cooper Block“), the Ministry has approved the entering into the next phase of the license. The Cooper Block license has been extended into the first Renewal Phase until March 14, 2018. Second Renewal phase is until March 2020.

In further recognition of the advancement of the exploration progress made on the Cooper Block, including over 1,000 km2 of 3D survey, the Ministry has waived the relinquishment requirement (as stipulated in the Petroleum Agreement), and the Block partners will continue the exploration work on the entire block area.

Eco Atlantic currently holds 32.5% carried interest in the Cooper Block and is Operator; AziNam holds 32.5%; Tullow Kudu Ltd. holds a 25% working interest and NAMCOR has a 10% carried interest in the Block.

Sharon Block (PEL_033)

In recognition of the Company and its Partners, AziNam and NAMCOR, having met and exceeded all exploration work obligations of the Initial Exploration Period as stipulated in the Petroleum Agreement, in Blocks 2213 A&B offshore Namibia (the “Sharon Block“), the Ministry has approved the entering into the next phase of the license. The Sharon Block license has been extended into the First Renewal Phase until March 14, 2018 and the completion of any 3D obligations will be extended to such date. Second Renewal phase is until March 2020.

The Ministry furthermore approved the Company’s request to terminate 50% of its licensing obligation corresponding with the relinquishment of 50% of the acreage in the license which was required in terms of the Petroleum Agreement. This relinquishment pertains to the eastern half of the Sharon Block. The Company considers this shallow section non-prospective.

Eco Atlantic holds a 60% participating interest in the Sharon Block and is Operator. AziNam holds 30% and NAMCOR has a 10% carried interest.

Guy Block (PEL_034)

In recognition of the Company and its Partners, AziNam and NAMCOR, having met and exceeded all exploration work obligations of the Initial Exploration Period as stipulated in the Petroleum Agreement, in Blocks 2111B and 2211A offshore Namibia (the “Guy Block“), including the shooting of over 1,000 km of new 2D lines and over 850 km2 of 3D survey, the Ministry has approved the entering into the next phase of the license. The Guy Block license has been extended into the First Renewal Phase until March 14, 2018. Second Renewal Phase is until March 2020.

The Ministry furthermore approved the Company’s request to terminate 50% of its licensing obligation corresponding with the relinquishment of 50% of the acreage in the license which was required in terms of the Petroleum Act. This relinquishment pertains to the western portion of the Guy block in the ultra-deep section, that the Company and its Operating Partner, AziNam, consider non-prospective.

The Company currently holds a 50% participating interest in the Guy Block, AziNam holds 40% and is Operator, and NAMCOR has a 10% carried interest.

Eco Atlantic CEO, Gil Holzman stated: “We are extremely happy with the Ministry’s positive decision to support our progression into the next exploration phase on our three core blocks offshore Namibia. Despite the constrained market conditions, and through efficient management of capital together with our valued partners, Tullow Kudu Ltd., AziNam and NAMCOR, our continuing financial and operational commitment to Namibia’s petroleum industry, has been recognized by the Government, by granting us the Approvals to enter next exploration phase on all 3 blocks and waiving the relinquishment requirement on the Cooper Block. With these approvals in hand as well as the reduction in required financial obligations, the Company, with its partners, are in a stronger position to continue to identify the most prospective targets and effectively optimize and complete the various exploration programs.”

About Eco Atlantic

Eco Atlantic is an oil and gas exploration company focused on the acquisition and development of unique upstream petroleum opportunities around the world. The Company’s objective is to identify technically merited prospective new and developing projects in frontier areas requiring low cost entry. In Namibia through wholly owned subsidiaries, the Company currently holds interests, some carried, in four offshore petroleum licenses in the Walvis and Lüderitz Basins.

In Ghana, Eco Atlantic also holds and operates an interest in the Deepwater Cape Three Points West Deep Water offshore block, covering 944 square kilometers and in Guyana, Eco Atlantic holds an interest in the 1,800 square kilometer Orinduik offshore block.

Eco Atlantic enjoys strong local presence in the countries in which it operates and has a longstanding relationship with the energy and oil and gas sectors throughout Africa and other maturing exploration plays internationally.

Forward Looking Statements

CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS: Certain information in this press release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expects” and similar expressions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with oil and gas production and exploration, marketing and transportation; retention of and ability to attract Company personnel, regulatory approvals, loss of markets; volatility of commodity prices; currency and interest rate fluctuations; imprecision of reserve estimates; environmental risks; competition; inability to access sufficient capital from internal and external sources; changes in legislation, including but not limited to income tax, environmental laws and regulatory matters. Readers are cautioned that the foregoing list of factors is not exhaustive.

Although Eco Atlantic believes in light of the experience of its officers and directors, current conditions, expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because Eco Atlantic can give no assurance that they will prove to be correct. The forward-looking statements contained in this press release are made as of the date hereof and Eco Atlantic undertakes no obligation to update publicly or revise any forward- looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

For More Information on Eco Atlantic Contact:

Gil Holzman
President and Chief Executive Officer
gil@ecooilandgas.com
Tel: +972.508884529 

Alan Friedman
Executive Vice President
alan@ecooilandgas.com
Tel: +1.416.250.1955

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE: Eco Atlantic Oil & Gas Ltd.

ReleaseID: 439282

MIRABEL, QC / ACCESSWIRE / April 27, 2016 / Urban Barns Foods Inc. (OTC: URBF) (“Urban Barns” or “the Company”), a vertical farming company that produces Kosher-certified leafy vegetables using its proprietary Cubic Farming™ technology, is pleased to provide this update to its shareholders.

Urban Barns recently participated in the SIAL Canada and SET Canada 2016 congress, held in Montréal, Québec. There were over 900 participants and approximately 16,000 visitors over the three days of this international food and beverage tradeshow. A great deal of interest was expressed for both the Company’s products as well as for its growing machines. Urban Barns’ business partners, Bevo Agro and Forty Foot Farms, have taken the patent pending Cubic Farming™ technology — a type of Controlled Environment Agriculture (CEA) — and made it possible for businesses and entrepreneurs to own and operate their very own “forty foot farm” by placing machines in containers. In addition they provide world-class systems, processes and support. Forty Foot Farms also recently attended the Nevada Indoor Agriculture Conference in Las Vegas.

The Company has received many enquiries from entities in the European Union, South America and the United States for opportunities to establish cubic farming operations by purchasing machines.

Customer demand continues to increase for all of Urban Barns’ products, including Kosher-certified lettuce and basil. The Company has expanded its varieties of microgreens it offers to clients, following requests from various chefs, to include pea shoots and additional herbs. Its lettuce, basil, and microgreens are now available in the retail market at Marché Bleuet in Montréal and Metro Glebe Market in Ottawa. Vargas Steakhouse, Hotel Bonaventure, and the Ritz-Carlton are but a few of the restaurants in Montréal that are featuring Urban Barns’ products on their menus.

“I am very pleased with the partnership with Bevo Agro and Forty Foot Farms,” Mr. Robyn Jackson, President and CEO of Urban Barns commented. “Creating the world`s most advanced shipping container and controlled environment Cubic Farming™ system will allow us to maintain our leadership in the CEA market.”

About Urban Barns Foods Inc.

Urban Barns uses patent pending and proprietary growing equipment to produce premium quality, chemical-free and non-GMO leafy vegetables in a secure and controlled indoor environment, including lettuce and basil that is Kosher-certified.

Forward-Looking Statements

Except for historical information contained herein, the matters set forth above may include forward-looking statements that involve certain risks and uncertainties. Words such as “may,” “could,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” and similar expressions are used to identify forward-looking statements. These forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements. Urban Barns does not undertake any obligation to update any forward-looking statements and cautions investors to consider all other risks and uncertainties, including those disclosed in Urban Barns’ filings with the United States Securities and Exchange Commission.

For further information, contact:

Urban Barns Foods Inc.
Robyn Jackson, President and CEO
rjackson@urbanbarns.com
Tel: +1 (403) 831-6720
www.urbanbarns.net

SOURCE: Urban Barns Foods Inc. 

ReleaseID: 439280

NEW YORK, NY / ACCESSWIRE / April 27, 2016 / InvestmentResearchReport.com is a small cap publication that uncovers extremely undervalued potential investment opportunities that have been overlooked by everyone else. Today we are taking a look at five companies which we believe could provide investors with potential upside volatility in the near term.

Investment Research Report believes that the cannabis sector represents an untapped source of potentially high returns. Recent moves by lawmakers suggest that more and more US states will join the current 24 which allow the use of cannabis either recreationally or for medical purposes. In researching the opportunities in the space we’ve uncovered a very credible opportunity that offers, based on underlying fundamentals and technicals, bullish near term to long term investing upside.

Grow Condos, Inc. (GRWC) is poised to take advantage of the expanding reach of the cannabis industry. The company currently operates as a real estate developer to the cannabis industry, providing the essential growing space and equipment infrastructure needed by those companies in the actual business of selling marijuana.

Breaking: See Why This Undiscovered Cannabis Stock Could Outperform Others In 2016

Within GRWC’s current portfolio is a 15,000 sq. ft. warehouse space that is managed on behalf of marijuana growers operating in Eagle Point, Oregon.
GRWC has a second project underway comprising 42,000 sq. ft. of warehouse condominiums for growers operating in the Pioneer Business Park in Eugene, Oregon. In recent news developments, GRWC has confirmed that it is actively seeking its third industrial condominium project; a development which management expects will be located outside the state of Oregon and thus broadening GRWC’s market reach.

Learn More About The Growth Potential Of GRWC

Any such expansion by GRWC will surely arrive at an opportune moment because the current outlook for the cannabis/marijuana industry is extremely bullish. In some quarters the industry is being hailed as the ideal startup opportunity and the historical growth numbers are progressively good.

Research data from Archview Group, a research firm that tracks the cannabis industry, estimates that total sales across the legal US cannabis industry reached $5.4B in 2015. The strong growth was a 17.9% increase over the $4.6B recorded the year prior and a major signal that there is proper sales momentum pushing the cannabis industry. The consensus among top industry watchers is that the cannabis industry will be a $20B industry at the end of the current decade. That consensus may or may not match the reality down the road but at current pace betting against it would be an investing mistake.

GRWC Has Just Received Substantial Funding

On April 19th GRWC announced that it signed an investment agreement with Tangiers Global LLC for up to $5 million in fixed funding commitments through an equity enhancement instrument.

GRWC stated that part of the funding will be used to expand their already functioning grow condo operations.

Current valuation pegs GRWC just under $1 but past movement suggests that current share price may just be a placeholder. Momentum is once again building and the growth of GRWC on the ground looks certain to coincide with the growth of the cannabis industry. Both present a unique and robust opportunity for strong investment returns.

Investment Research Report will be tracking GRWC as it develops both its operations and near term upside potential. Subscribers are therefore encouraged to keep abreast so that opportunities for strong returns can be seized if and when they arise.

Want The Inside Scoop On GRWC Before The Street Catches On?

Shares of Sarepta Therapeutics, Inc. (SRPT) were hit hard on Tuesday gapping down from Mondays $14.95 close due to news that an FDA panel voted against one of the companies lead drug candidates. Shares however were resilient and after opening around $8 on Tuesday managed to close the day over $11.

OncoGenex Pharmaceuticals, Inc. (OGXI) was another biotech that was in play on Tuesday with shares rallying 24 cents or 22% on well above average volume.

Ocean Rig UDW Inc. (ORIG) Shares were trading higher on news that the company agreed to acquire an ultra-deepwater drillship for less than one-tenth of its build price.

VirnetX Holding Corp (VHC) was another stock that was trending higher on Tuesday with shares closing the day at $4.95, up 11% on the day. The company has been in the news most recently due to a substantial patent win over Apple, Inc.

Out Of All The Stocks Mentioned See Which One We Think Has The Biggest Growth Potential

About InvestmentResearchReport.com:

InvestmentResearchReport.com is a small cap publication that uncovers extremely undervalued potential investment opportunities that have been overlooked by everyone else.

Want More Info On Breaking Investment Opportunities? CLICK HERE

Disclosure: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. InvestmentResearchReport.com has not been compensated nor expects to receive any compensation for distribution of our opinions and publicly available information for SRPT, OGXI, ORIG nor VHC as of 4/27/2016. InvestmentResearchReport.com has been compensated $10,000 by a 3rd party, DF Media LLC for our coverage of GRWC. Owners and operators of InvestmentResearchReport.com hold no positions in any of the stocks mentioned in this release as of 04/27/2016. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Please visit the Investment Research Report website for complete risks and disclosures.

SOURCE: InvestmentResearchReport.com

ReleaseID: 439263

NEW YORK, NY / ACCESSWIRE / April 27, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. MWOG, ASTI, TPIV and PPCH are on high volume watch, particularly MWOG. Continue reading to find out why these stocks are getting so much interest today. – If you want reports on the day’s hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.

Midwest Oil and Gas Inc. (OTC: MWOG) Is an exploration stage company that engages in the exploration, development, and production of onshore oil and natural gas reserves.

Shares of MWOG are trading higher by over 600% pre-market this morning and is showing a $0.39 cent gap in share price from its previous close. After the market opened, the stock doubled from its pre-market high and is now trading higher by almost 1,300%.

The stock is bringing in a lot of volume compared to its average volume and this extra attention probably won’t go unnoticed.

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Ascent Solar Technologies, Inc. (NASDAQ: ASTI) Is a development stage company that designs and manufactures photovoltaic integrated consumer electronics; and portable power applications for commercial and military users.

Shares of ASTI have been relatively stagnant in April and appear to be trending lower. After a big day in mid march, the stock has continued a trend of downward action.

As volume continues to get lighter on this stock, chances are it will continue to drop, however, the stock is known to have big short-term bursts in share price and volume.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

TapImmune, Inc. (OTCQB: TPIV) Is a clinical-stage immunotherapy company that develops peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and infectious diseases.

Shares of TPIV traded higher yesterday off heavier than usual volume after AstraZeneca announced that they were increasing their immune-oncology with TPIV.

A joint AstraZeneca-TapImmune Phase 2 ovarian cancer trial will start this quarter at the prestigious Sloan Kettering Institute, according to a press release issued a few days ago.

We are watching TPIV to see if it can hold on to and build off of yesterday’s gains.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

Propanc Health Group Corporation (OTCQB: PPCH) Is a development stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic and colorectal cancer in Australia.

Shares of PPCH traded higher yesterday by over 16% and the stock has been on a steady rise ever since announcing last week that it had filed two more patent applications in the United States regarding new compositions of its lead product, PRP, for treating cancer.

In early March, PPCH received an influx of share volume that pushed the stock higher by 500%. PPCH received a similar amount of volume the last few trading periods and it is looking like that kind of momentum could continue throughout the rest of the week.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About otc-expert.com

The OTC Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “OTCLEADER”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The OTC Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The OTC Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit otc-expert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The OTC Expert
info@otc-expert.com

SOURCE: The OTC Expert

ReleaseID: 439278

LOS ANGELES, CA / ACCESSWIRE / April 27, 2016 / April 28, 2016 at 6pm, Angelenos will gather to celebrate five incredible leaders making a profound difference through community engagement at the historic Biltmore Hotel. Familia Unida Living with MS, a LA based MS non-profit organization, is ringing in 20 years of service by recognizing inspirational community leaders.

Familia Unida is delighted and thrilled that JM Longoria who is featured in the newly released film “Miracles from Heaven,” will be joining as the Master of Ceremonies. The characters in this inspiring movie help us to remember that there is hope which closely compliments the non-profits mission. “I am incredibly humbled and honored to be invited to partake as the Masters of Ceremonies for the Familia Unida 20th Anniversary of Service Celebration. It gives me great pleasure to help celebrate the selfless acts of others that continuously share their love and commitment for the sole purpose of inspiring others while making a profound impact within our diverse community. I look forward to meeting these individuals and learning more about how we can continue to further support our brothers and sisters,” said JM Longoria.

Community Leader, Activist, and Angeleno receiving the “Distinguished Amigo Advocate” Recognition

– David Damian Figueroa, A Community Advocate is a long time supporter of “Familia Unida.” Mr. Figueroa will receive the “Distinguished Amigo Award” for his dedication to advocate and bring awareness to many worthy causes through his leadership and wealth of expertise. David Damian Figueroa is currently the AVP, of Community Engagement for the Frontier Communications West Region. He is the former Vice President of Strategic Development and Communications for MALDEF where he was charged in developing strategic partnerships with donors and in developing the organizations public profile. His background and expertise in government affairs, media relationships, foundation partnerships, civic engagement has earned him the respect from his peers and community at large. David Damian’s personal commitment for positive social change and volunteering for worthy causes including the Dolores Huerta Foundation, The Cesar Chavez Foundation, Familia Unida Living with MS, and being a prominent voice within the LBGT community and immigration causes has earned him numerous recognitions.

Champion of Amor Honoree – Familia Unida Gala 20 years of Service

– Dr. David Saperia, Leading Neurologist at Rancho Los Amigos: Dr. Saperia will be recognized for his passion to better serve his patients which has been his lifetime commitment while also bridging a wide range of medical expertise and holistic treatment simply because he cares to offer the best options. Dr. Saperia has touched and cared for countless patients throughout his impressive career. He is has also served on the board of directors for Familia Unida and is currently a Board Ambassador.

Community Leader and Champion of Hope Honoree

– Elizabeth Espinosa, Emmy award winning KFI-AM 640 talkradio host, PBS SoCal “Studio So Cal” tv host, and KTLA-5 News Reporter/Anchor, who was recently named by the “The Hollywood Reporter” as one of Hollywood’s Most Powerful Latino Talent Under 40 in the entertainment industry will be recognized for her tireless special needs advocacy work in the community and across the country. Elizabeth is also a special needs advocate and supports a number of important charities across the country, including the Epilepsy Foundation of America and The Epilepsy Foundation of Greater Los Angeles. She is also passionate about Autism Awareness as it is a cause close to her heart. Elizabeth Espinosa is a voice for the community and we are witnesses to the many ways that she brings awareness many important causes.

Angeleno and Champion of Inspiration Honoree – Familia Unida Gala 20 years of Service – Community Leader

– Ivan Estrella will be recognized for being an outstanding example of courage, confidence and compassion through his musical talent that touches hearts and inspires us to pursue our dreams with positivity and love. Ivan is living with the diagnosis of Multiple Sclerosis since he was 13 and is legally blind. Ivan expresses that this can be scary and unpredictable. Ivan has also mentored children with musical training and fun activities at Alta Loma Elementary School, Plaza De La Raza, and Sabor De Mexico School of Performing Arts, El Arca, the Special Olympics World Games to name a few. Ivan never stopped pursuing his education, desire to give back to the community, and share his knowledge with others in need. His career as a Professional Mariachi Singer and Musician continues to flourish.

Master of Ceremonies Familia Unida Gala 20 years of Service honoring community leaders

About Familia Unida Living with MS:

Familia Unida Living with MS was created 20 years ago. Familia Unida has evolved and today serves over 15,000 individuals living with MS and a variety of disabilities. Familia Unida invites you to spread awareness of their motto “You are not alone – No estas solo” and embrace your family and loved ones. The Dinner Gala is a wonderful way to celebrate 2 decades of service, raise funds to support our vital programs and recognize impactful individuals. to learn more www.lovefamiliaunida.org.

According to the MS Foundation, every day someone in the United States is diagnosed with MS, about 200 new cases are diagnosed each week. There are more than 400,000 people living with MS in the United States and about 2.5 million worldwide. This does not include many who are not diagnosed or missed diagnosed due to language and cultural barriers, said Familia Unida’s Founder, Irma Resendez. To learn more about Familia Unida, donate or volunteer please visit http://www.lovefamiliaunida.org or call 323.418.2667

Celebrating 20 years of service honoring community leaders.

SOURCE: Familia Unida Living with MS

ReleaseID: 439273

SEATTLE, WA / ACCESSWIRE / April 27, 2016 / Jerrick Media Holdings Inc. (OTCQB: JMDA), a digital media and technology company focused on branded digital content and e-commerce, recently announced the planned launch of Potent.Media in June of this year as its initial foray into the burgeoning cannabis industry.

In conjunction with the June launch Jerrick will be collaborating with LadyPants Productions to release Baked, the first in a three-part digital series focused on cannabis. Baked is a cooking show focused on a unique ingredient, cannabis. It will feature Vancouver celebrity Mary Jean Dunsdon, who has been cooking pot-infused treats for more than 13 years and has been featured in numerous popular cannabis and mainstream publications, including The
Daily Mail, High Times, and The New
York Post.

As part of the creative collaboration, Jerrick Media will develop, finance, and distribute the three-part short series that will include Baked,
Marijuana Minute, and Stoners in Stilettos. LadyPants Productions – headed by the award winning producer and TV host Fiona Forbes and singer songwriter Mary Zilba – will be responsible for creative content, writing, and direction.

Targeting an Attractive Niche

The cannabis industry could be worth as much as $35 billion by 2020, according to GreenWave
Advisors. There are many different types of companies operating within the industry, but media side of the business is especially compelling.

The legalization of medical and recreational marijuana throughout a growing number of states has increased demand for cannabis-related media. For instance, the Denver Post launched The Cannabist back in 2013 shortly before the state legalized recreational marijuana. The website has since grown in popularity and become the 11,108 most popular website in the U.S. and the 49,075 most popular website in the world, according to Alexa rankings.

The growing number of cannabis-related business, ranging from dispensaries to vaporizer manufacturers, has also created demand for advertisements. Unlike traditional firms, these companies can’t leverage mainstream advertising outlets like Google AdWords or Facebook Ads to reach targeted audiences, since marijuana remains illegal on a federal level. Cannabis publishers have a unique opportunity to capitalize on this demand with premium rates.

A Unique Leadership Team

Rick Schwartz and Jeremy Frommer founded Jerrick Media to combine their talents in creative production and Wall Street finance.

Rick Schwartz is best known for producing The Departed, Black Swan, Gangs of New York, The Others, and Lip Sync Battle, among other projects. After starting his career working under Harvey and Bob Weinstein at Miramax, he became the company’s senior vice president of production before founding Overnight Productions in 2008. That company financed and produced movies by directors including Robert Rodriguez and Darren Aronofsky.

Jeremy Frommer comes from the other side of the aisle, having worked for over two decades on Wall Street as a hedge fund portfolio manager and founded and sold two financial services companies. As a seasoned executive and investor, he complements Schwartz’s creative background with a quantitative financial background to help build long-term shareholder value.

Most small companies were either started by a visionary or a financial expert, but few have both ingredients needed for long-term success.

Innovative Tech Platform

Jerrick Media’s creative production represents only half of the equation when it comes to its long-term business plan. In order to distribute and monetize the content, the company has developed an innovative content management platform known as Forum.

The powerful interface enables non-web designers to create rich user experiences including articles, videos, galleries, and libraries. In addition, it seamlessly integrates e-commerce and other features designed to effectively monetize content. Users can manage and monetize their content from a single source, while publishing it across many different media outlets in order to streamline operations and simplify the management of their media network.

The Forum platform is being initially deployed internally to manage the company’s growing number of media properties, but management hopes to expand the product into a standalone solution for other media companies looking to streamline their operations. This could create an entirely new revenue stream from software sales and licensing over the long-term, while helping keep its costs down and revenue up over the short-term.

Looking Ahead

Jerrick Media represents a unique opportunity in the cannabis industry. In a single company, investors can access two seasoned executives – one creative and one financial – along with a robust production studio and potential software play down the road.

The company’s production studio approach is to target niche verticals, which means that investors in companies like Eco Science Solutions Inc. (OTC Pink: ESSI), Everyday Health Inc. (NYSE: EVDY), or Remark Media Inc. (NASDAQ: MARK) may want to take a closer look. On the software side, investors in companies like Bridgeline Digital Inc. (NASDAQ: BLIN) or BroadVision Inc. (NASDAQ: BVSN) may want to take a look at the company’s Forum software.

For more information about Jerrick Media, visit the company’s website at www.jerrickmedia.com.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Important factors that could cause these differences include, but are not limited to, the demand for the company’s services, governmental regulation of the cannabis industry, and the company’s ability to execute its business plan. Emerging Growth LLC dba TDM Financial, which owns CFN Media, is not registered with any financial or securities regulatory authority, and does not provide nor claim to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CFN Media, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

SOURCE: CFN Media

ReleaseID: 439274